Recent articles
Better Buy: Disney vs. Netflix
Will Netflix remain the king of all streaming, or will Disney topple the upstart?
Where Will Square Be in 10 Years?
It might morph into an incredibly valuable financial services company, or even a super-bank.
2 Stocks That Are Absurdly Cheap Right Now
The stock market is severely underpricing a gaming stock for your smart phone and a speed-boat manufacturer.
3 Cancer Treatment Stocks to Buy Right Now
MIrati Therapeutics, Iovance Biotherapeutics, and Personalis are all using genetic knowledge to help find cures for cancer.
Could Novavax Be a Millionaire-Maker Stock?
This tiny biotech has a long history of failure, but it also has a flu vaccine that is likely to be approved by the FDA.
Is Smartsheet in Danger of Being Crushed by Microsoft?
Microsoft has a flaw, and tiny Smartsheet is taking advantage of it.
Is It Time to Buy Ubisoft?
This French video-game company's stock has taken a big hit, but we like what it has in store.
1 No-Brainer Pharmaceutical Stock to Buy
It's highly likely that Immunomedics' billion-dollar drug will finally be approved by the FDA.
Why Orthodontists Are Scared of SmileDirectClub
An online startup is disrupting an industry with a cheaper and easier alternative.
Why Shockwave Medical Is Not a Buy
It's an amazing company with fantastic revenue growth. But there's one small problem that's keeping me on the sidelines.
A Nightmare on IPO Street?
When it comes to investing in IPOs like Beyond Meat safely, don't forget to factor in the Unlocking of the Shares.
Why Did the Market Strike Down CrowdStrike?
A great company just went on sale.
Is Visa Scared of Afterpay?
The payments business is being invaded from Down Under by a company that wants you to afterpay your big purchases.
Who Is Right About Farfetch: GQ or Wall Street?
Wall Street hated the New Guards acquisition. But maybe the fashion industry knows something the Street is missing.
Why Did the Market Whack This IPO?
The stock of Vir Biotechnology lost 30% of its value on its first day of trading.
Big Pharma Has Mad Love For These 2 Biotechs
These companies' collaborations with bigger businesses validates their science -- and paves the way for future revenues and profits.
Is Carvana The Amazon Of Cars?
An internet retailer is in the midst of disrupting a massive industry, and it's happening right before our eyes.
2 Small Caps That Are Winning in the Oil Patch
A picks-and-shovels play and a Permian Basin pipe operator are energetic picks in a volatile space.
How Fishy Is This Fish Oil Pill?
Amarin's Vascepa just might be a blockbuster.
A Biotech Set to Dominate the Next 20 Years
Ionis Pharma has some powerful numbers now. But its future opportunities are even more amazing.